4-arylindoline thiazole analog PD-1/PD-Ll interaction inhibitor (Shenyang Pharmaceutical University/Sun Yat-Sen University)

N/A

Report date: 2025/01/26 18:50:09
NME

Base Information

Drug Name4-arylindoline thiazole analog PD-1/PD-Ll interaction inhibitor (Shenyang Pharmaceutical University/Sun Yat-Sen University)
Drug Alias NamePD-1/PD-Ll checkpoint inhibitor (Shenyang Pharmaceutical University/Sun Yat-Sen University)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProgrammed death-ligand 1 blockersProgrammed cell death protein 1 blockers
TargetsProgrammed death-ligand 1Programmed cell death protein 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShenyang Pharmaceutical University
China Registration ClassN/A

Develop Information

Active CompaniesShenyang Pharmaceutical UniversitySun Yat-Sen University
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A